• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道微生物群定植对儿童呼吸道合胞病毒感染短期和长期结局的影响:一项范围综述。

Effect of respiratory microflorae colonization on short and long-time outcomes of respiratory syncytial virus infection in children: A scoping review.

作者信息

Gan Lidan, Liu Enmei, Deng Yu

机构信息

Department of Respiratory Medicine Children's Hospital of Chongqing Medical University Chongqing China.

Ministry of Education Key Laboratory of Child Development and Disorders Children's Medical Big Data Intelligent Application Center Department of Respiratory Medicine Chongqing China.

出版信息

Pediatr Discov. 2024 Jul 16;2(4):e97. doi: 10.1002/pdi3.97. eCollection 2024 Dec.

DOI:10.1002/pdi3.97
PMID:40626129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12118256/
Abstract

Respiratory syncytial virus (RSV) is an essential cause of lower respiratory tract infection in children under 2 years of age, especially under 6 months. In decades, studies have shown that the respiratory tract microflorae with RSV infection were related to disease severity and played a role in the development of recurrent wheezing, but the effect of respiratory microflorae on RSV infection are still underestimated. This study aims to conclude the effect of respiratory microflorae colonization on RSV infectious disease severity and recurrent wheezing and provide suggestions for future research directions from the perspective of respiratory tract florae. We conducted a scoping review. Studies were eligible if they reported on the effect of microflorae on RSV infectious diseases among children. We exacted the following information: title, publication time, first author's country, and article type. We finally included 33 articles in this scoping review. The number of studies rapidly increased since 2013 and the highest number of hospitalizations were reported in children <2 years. More than half (69.70%) were conducted in America and most studies are original studies (57.58%). The Review highlighted that the respiratory microflorae played an important role in RSV infectious disease severity and recurrent wheezing. We found that (S.pn), (HI), (M.ca), and (SA) were the dominant profiles in children with RSV infection. Understanding the respective role of respiratory microflorae on RSV infection and its mechanisms would improve prevention and treatment strategies from the perspective of microflorae.

摘要

呼吸道合胞病毒(RSV)是2岁以下儿童,尤其是6个月以下儿童下呼吸道感染的重要病因。几十年来,研究表明,RSV感染时的呼吸道微生物群与疾病严重程度相关,并在复发性喘息的发展中起作用,但呼吸道微生物群对RSV感染的影响仍被低估。本研究旨在总结呼吸道微生物群定植对RSV感染性疾病严重程度和复发性喘息的影响,并从呼吸道菌群的角度为未来的研究方向提供建议。我们进行了一项范围综述。如果研究报告了微生物群对儿童RSV感染性疾病的影响,则该研究符合纳入标准。我们提取了以下信息:标题、发表时间、第一作者所在国家和文章类型。我们最终在本范围综述中纳入了33篇文章。自2013年以来,研究数量迅速增加,2岁以下儿童的住院人数报告最多。超过一半(69.70%)的研究在美国进行,大多数研究是原创研究(57.58%)。该综述强调,呼吸道微生物群在RSV感染性疾病严重程度和复发性喘息中起重要作用。我们发现,肺炎链球菌(S.pn)、流感嗜血杆菌(HI)、卡他莫拉菌(M.ca)和金黄色葡萄球菌(SA)是RSV感染儿童中的主要菌群。了解呼吸道微生物群对RSV感染的各自作用及其机制将从微生物群的角度改善预防和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/12118256/6117bb54b4c7/PDI3-2-e97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/12118256/80c034f965d8/PDI3-2-e97-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/12118256/6117bb54b4c7/PDI3-2-e97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/12118256/80c034f965d8/PDI3-2-e97-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/12118256/6117bb54b4c7/PDI3-2-e97-g002.jpg

相似文献

1
Effect of respiratory microflorae colonization on short and long-time outcomes of respiratory syncytial virus infection in children: A scoping review.呼吸道微生物群定植对儿童呼吸道合胞病毒感染短期和长期结局的影响:一项范围综述。
Pediatr Discov. 2024 Jul 16;2(4):e97. doi: 10.1002/pdi3.97. eCollection 2024 Dec.
2
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒(RSV)感染。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
3
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
4
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
5
Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review.成人对呼吸道合胞病毒感染的宿主免疫反应及其对保护作用和易感性的影响:一项系统文献综述
Expert Rev Clin Immunol. 2025 Jun;21(6):745-760. doi: 10.1080/1744666X.2025.2494658. Epub 2025 May 2.
6
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.使用帕利珠单抗对儿童进行呼吸道合胞病毒(RSV)免疫预防:一项系统评价与经济学评估
Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. doi: 10.3310/hta12360.
7
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
Lower respiratory tract co-infection of and respiratory syncytial virus shapes microbial landscape and clinical outcomes in children.副流感病毒与呼吸道合胞病毒的下呼吸道合并感染塑造了儿童的微生物格局和临床结局。
Front Cell Infect Microbiol. 2025 Jun 9;15:1593053. doi: 10.3389/fcimb.2025.1593053. eCollection 2025.

本文引用的文献

1
[Impact of colonization in upper airway on the clinical manifestations of children with respiratory syncytial virus infection].[上呼吸道定植对呼吸道合胞病毒感染儿童临床表现的影响]
Zhonghua Er Ke Za Zhi. 2022 Jul 2;60(7):694-699. doi: 10.3760/cma.j.cn112140-20220227-00156.
2
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
3
Location matters in RSV protection.
RSV 保护中,位置很重要。
Cell Host Microbe. 2022 Jan 12;30(1):15-16. doi: 10.1016/j.chom.2021.12.012.
4
Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.宏转录组学直接从临床样本中描述呼吸病毒组、微生物组和宿主反应。
Cell Rep Methods. 2021 Oct 25;1(6). doi: 10.1016/j.crmeth.2021.100091.
5
Maternal gut microbiome regulates immunity to RSV infection in offspring.母体肠道微生物组调节后代对 RSV 感染的免疫。
J Exp Med. 2021 Nov 1;218(11). doi: 10.1084/jem.20210235. Epub 2021 Oct 6.
6
Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.鼻咽部流感嗜血杆菌和肺炎链球菌共检测影响儿童呼吸道合胞病毒疾病结局。
J Infect Dis. 2022 Mar 2;225(5):912-923. doi: 10.1093/infdis/jiab481.
7
Upper respiratory tract bacterial-immune interactions during respiratory syncytial virus infection in infancy.婴幼儿呼吸道合胞病毒感染时的上呼吸道细菌-免疫相互作用。
J Allergy Clin Immunol. 2022 Mar;149(3):966-976. doi: 10.1016/j.jaci.2021.08.022. Epub 2021 Sep 14.
8
The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population.阿奇霉素预防重症呼吸道合胞病毒细支气管炎后喘息-II期临床试验:原理、研究设计、方法及研究人群特征
Contemp Clin Trials Commun. 2021 Jun 9;22:100798. doi: 10.1016/j.conctc.2021.100798. eCollection 2021 Jun.
9
Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis.患有和未患呼吸道合胞病毒细支气管炎的婴儿的鼻腔和粪便微生物群及免疫分析
Front Microbiol. 2021 Jun 1;12:667832. doi: 10.3389/fmicb.2021.667832. eCollection 2021.
10
Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma.整合组学对呼吸道合胞病毒毛细支气管炎婴儿的表型分析与儿童哮喘风险的关系。
Nat Commun. 2021 Jun 14;12(1):3601. doi: 10.1038/s41467-021-23859-6.